Calculation
P/S | = | Share price1, 2, 3 | ÷ | Sales per share1 | Sales per share1 | = | Revenues from customers1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 12, 2025 | 0.22 | = | 63.22 | ÷ | 293.99 | 293.99 | = | 370,656 | ÷ | 1,260,795,063 | |
Feb 7, 2024 | 0.27 | = | 76.05 | ÷ | 283.38 | 283.38 | = | 356,623 | ÷ | 1,258,449,553 | |
Feb 8, 2023 | 0.36 | = | 88.96 | ÷ | 250.47 | 250.47 | = | 321,629 | ÷ | 1,284,111,667 | |
Feb 9, 2022 | 0.47 | = | 104.79 | ÷ | 221.65 | 221.65 | = | 290,912 | ÷ | 1,312,510,426 | |
Feb 16, 2021 | 0.35 | = | 70.53 | ÷ | 204.30 | 204.30 | = | 267,908 | ÷ | 1,311,354,926 | |
Feb 18, 2020 | 0.37 | = | 72.00 | ÷ | 196.11 | 196.11 | = | 255,765 | ÷ | 1,304,159,680 | |
Feb 28, 2019 | 0.39 | = | 57.83 | ÷ | 149.50 | 149.50 | = | 193,919 | ÷ | 1,297,082,165 | |
Feb 14, 2018 | 0.38 | = | 69.79 | ÷ | 182.12 | 182.12 | = | 184,765 | ÷ | 1,014,532,157 | |
Feb 9, 2017 | 0.45 | = | 77.31 | ÷ | 173.08 | 173.08 | = | 177,526 | ÷ | 1,025,699,605 | |
Feb 9, 2016 | 0.65 | = | 90.51 | ÷ | 139.55 | 139.55 | = | 153,290 | ÷ | 1,098,490,835 | |
Feb 10, 2015 | 0.82 | = | 101.68 | ÷ | 123.85 | 123.85 | = | 139,367 | ÷ | 1,125,252,739 | |
Feb 11, 2014 | 0.64 | = | 68.77 | ÷ | 107.20 | 107.20 | = | 126,761 | ÷ | 1,182,427,156 | |
Feb 15, 2013 | 0.51 | = | 51.12 | ÷ | 100.01 | 100.01 | = | 123,133 | ÷ | 1,231,194,296 | |
Feb 17, 2012 | 0.54 | = | 44.27 | ÷ | 82.23 | 82.23 | = | 107,100 | ÷ | 1,302,378,570 | |
Feb 18, 2011 | 0.47 | = | 33.06 | ÷ | 70.47 | 70.47 | = | 96,413 | ÷ | 1,368,174,000 | |
Feb 26, 2010 | 0.48 | = | 33.75 | ÷ | 71.00 | 71.00 | = | 98,729 | ÷ | 1,390,515,000 | |
Feb 27, 2009 | 0.43 | = | 25.74 | ÷ | 60.10 | 60.10 | = | 87,472 | ÷ | 1,455,515,000 | |
Feb 27, 2008 | 0.76 | = | 40.48 | ÷ | 53.31 | 53.31 | = | 76,330 | ÷ | 1,431,879,000 | |
Feb 27, 2007 | 0.60 | = | 31.50 | ÷ | 52.93 | 52.93 | = | 43,814 | ÷ | 827,838,000 | |
Mar 14, 2006 | 0.68 | = | 30.57 | ÷ | 45.27 | 45.27 | = | 37,006 | ÷ | 817,412,000 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-29), 10-K (reporting date: 2006-12-30), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of CVS Health Corp. Annual Report.
- Share Price Trend
- The share price demonstrated notable fluctuations over the analyzed period. Initially, it increased from 30.57 in 2006 to a peak of 101.68 in early 2015. However, after this peak, the share price generally declined, falling to 63.22 by early 2025. This indicates a period of significant growth followed by a gradual decrease in market valuation.
- Sales per Share Trend
- Sales per share showed a consistent upward trajectory throughout the entire period, rising from 45.27 in 2006 to 293.99 by 2025. This increase reflects a strong and sustained growth in revenue on a per-share basis, suggesting improved business performance and operational scaling over time.
- Price-to-Sales (P/S) Ratio Trend
- The P/S ratio exhibited a declining trend across the years. Starting at 0.68 in 2006, it fell to 0.22 by 2025. This decline, despite increasing sales per share, suggests that the share price did not keep pace with revenue growth, leading to a lower valuation multiple. This pattern could indicate market concerns about profitability, competitive pressures, or other factors influencing investor sentiment.
- Combined Analysis
- The data suggests that while the company effectively grew its sales per share, this operational success did not translate proportionally into sustained share price appreciation in the long term. Early strong price growth was followed by a reduction in valuation multiples, as seen in the falling P/S ratio, which might reflect investor reassessment of growth prospects or changing market conditions.
Comparison to Competitors
CVS Health Corp. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
---|---|---|---|---|---|---|
Feb 12, 2025 | 0.22 | 5.58 | 0.51 | 24.42 | 3.18 | 1.08 |
Feb 7, 2024 | 0.27 | 4.93 | 0.70 | 18.71 | 3.72 | 1.25 |
Feb 8, 2023 | 0.36 | 4.25 | 362,239.81 | 13.81 | 3.72 | 1.40 |
Feb 9, 2022 | 0.47 | 4.78 | 0.81 | 17.89 | 5.57 | 1.58 |
Feb 16, 2021 | 0.35 | 6.30 | 0.60 | 21.29 | 4.36 | 1.24 |
Feb 18, 2020 | 0.37 | 4.83 | 0.74 | 15.01 | 4.36 | 1.18 |
Feb 28, 2019 | 0.39 | 4.37 | 0.88 | 16.06 | 3.92 | 1.12 |
Feb 14, 2018 | 0.38 | 3.84 | 0.67 | 14.97 | 4.06 | 1.10 |
Feb 9, 2017 | 0.45 | 3.70 | 0.51 | 10.11 | 4.07 | 0.83 |
Feb 9, 2016 | 0.65 | 2.78 | 0.42 | 8.46 | 5.36 | 0.68 |
Feb 10, 2015 | 0.82 | 3.53 | 0.54 | 8.80 | 3.74 | 0.80 |
Feb 11, 2014 | 0.64 | 2.74 | 0.35 | 6.76 | 3.13 | 0.57 |
Feb 15, 2013 | 0.51 | 1.38 | 0.31 | 10.56 | 2.36 | 0.53 |
Feb 17, 2012 | 0.54 | 2.27 | 0.37 | 11.00 | 2.60 | 0.55 |
Feb 18, 2011 | 0.47 | 2.06 | 0.44 | 9.15 | 2.48 | 0.50 |
Feb 26, 2010 | 0.48 | 2.74 | 0.43 | 12.01 | 2.54 | 0.44 |
Feb 27, 2009 | 0.43 | 2.83 | 0.33 | 5.14 | 4.30 | 0.43 |
Feb 27, 2008 | 0.76 | 3.31 | 0.67 | 19.21 | 4.74 | 0.81 |
Feb 27, 2007 | 0.60 | 3.68 | 0.89 | 11.23 | 4.81 | 1.03 |
Mar 14, 2006 | 0.68 | 3.02 | 1.14 | 15.19 | 6.30 | 1.78 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-29), 10-K (reporting date: 2006-12-30), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
CVS Health Corp. | Health Care Equipment & Services | |
---|---|---|
Feb 12, 2025 | 0.22 | 1.11 |
Feb 7, 2024 | 0.27 | 1.15 |
Feb 8, 2023 | 0.36 | 64,004.93 |
Feb 9, 2022 | 0.47 | 1.48 |
Feb 16, 2021 | 0.35 | 1.29 |
Feb 18, 2020 | 0.37 | 1.21 |
Feb 28, 2019 | 0.39 | 1.25 |
Feb 14, 2018 | 0.38 | 1.16 |
Feb 9, 2017 | 0.45 | 1.00 |
Feb 9, 2016 | 0.65 | 0.98 |
Feb 10, 2015 | 0.82 | 1.08 |
Feb 11, 2014 | 0.64 | 0.84 |
Feb 15, 2013 | 0.51 | 0.73 |
Feb 17, 2012 | 0.54 | 0.88 |
Feb 18, 2011 | 0.47 | 0.80 |
Feb 26, 2010 | 0.48 | 0.84 |
Feb 27, 2009 | 0.43 | 0.87 |
Feb 27, 2008 | 0.76 | 1.26 |
Feb 27, 2007 | 0.60 | 1.42 |
Mar 14, 2006 | 0.68 | 1.82 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-29), 10-K (reporting date: 2006-12-30), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
CVS Health Corp. | Health Care | |
---|---|---|
Feb 12, 2025 | 0.22 | 2.61 |
Feb 7, 2024 | 0.27 | 2.72 |
Feb 8, 2023 | 0.36 | 39,755.53 |
Feb 9, 2022 | 0.47 | 2.65 |
Feb 16, 2021 | 0.35 | 2.59 |
Feb 18, 2020 | 0.37 | 2.51 |
Feb 28, 2019 | 0.39 | 2.51 |
Feb 14, 2018 | 0.38 | 2.49 |
Feb 9, 2017 | 0.45 | 2.29 |
Feb 9, 2016 | 0.65 | 2.30 |
Feb 10, 2015 | 0.82 | 2.62 |
Feb 11, 2014 | 0.64 | 2.38 |
Feb 15, 2013 | 0.51 | 1.87 |
Feb 17, 2012 | 0.54 | 1.66 |
Feb 18, 2011 | 0.47 | 1.57 |
Feb 26, 2010 | 0.48 | 1.77 |
Feb 27, 2009 | 0.43 | 1.47 |
Feb 27, 2008 | 0.76 | 2.14 |
Feb 27, 2007 | 0.60 | 2.60 |
Mar 14, 2006 | 0.68 | 2.90 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-29), 10-K (reporting date: 2006-12-30), 10-K (reporting date: 2005-12-31).